We are looking forward to celebrating #HAEDay on May 16th, when we join the global community to raise awareness about this rare disease and the impact it has on those living with it. Together, we can work toward a future where everyone has access to the care and support they need. We stand with the HAE community on HAE Day and every day.
BioCryst Pharmaceuticals, Inc.
Biotechnology Research
Durham, NC 30,998 followers
We develop oral small-molecule and protein therapeutics to target complement-mediated and other rare diseases.
About us
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with complement-mediated and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. We are a commercial-stage biotech company with US headquarters in Durham, North Carolina. Our European headquarters is in Dublin, Ireland, and our Discovery Center of Excellence is rooted in Birmingham, Alabama, with many other regional offices around the world. As world leaders in structure-guided drug design, we draw on the strengths and expertise of all our colleagues—from those of us in the field or behind the scenes in our labs, to others based in home offices and around the globe. To view our LinkedIn community guidelines, please visit bit.ly/BCRXGuidelines.
- Website
-
https://www.biocryst.com
External link for BioCryst Pharmaceuticals, Inc.
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Durham, NC
- Type
- Public Company
- Founded
- 1986
- Specialties
- Drug Discovery, Clinical Development, Rare Diseases, Regulatory Affairs, and Product Commercialization
Locations
-
Primary
Get directions
4505 Emperor Blvd.
Suite 200
Durham, NC 27703, US
-
Get directions
2100 Riverchase Center
Birmingham, Alabama 35244, US
-
Get directions
Dublin, IE
Employees at BioCryst Pharmaceuticals, Inc.
Updates
-
For Lauren Mills, Senior Manager, Global Patient Advocacy, #PrideMonth is a time to recognize the progress and advocacy efforts made by the LGBTQ+ community. #Pride2024
-
-
Today, we join the nation in celebrating #Juneteenth, the day when slavery officially came to an end in the United States. Honoring this day reflects the core values of our company and our dedication to creating a workplace that embraces diversity and the rich tapestry of our shared history. We stand together in unity, recognizing the significance of Juneteenth and its enduring legacy.
-
-
During #PrideMonth we reaffirm our commitment to #equality. It is a reminder of how important it is to encourage everyone to be their most authentic selves and nurture a culture of inclusion and belonging.
-
-
Netherton syndrome is a rare disorder affecting the skin, hair, and immune system. Patients generally present at birth with generalized erythroderma and scaling, and failure to thrive. Learn more: https://lnkd.in/ggGA2ips
-
-
We recently launched the report “The power of partnership: shared decision making in HAE” in the United Kingdom. In collaboration with HAE UK, we carried out in-depth research into the use of shared decision making (SDM) in the management of hereditary angioedema (HAE), a potentially life-threatening rare disease. The report summarizes our findings and recommendations. Learn more: https://lnkd.in/ejhzvhwG
-
-
It was wonderful to connect with the broader #HAE community and collaborate with our industry colleagues in the allergy and immunology field at the European Academy of Allergy and Clinical Immunology - EAACI Congress 2024. #EAACI2024
-
-
#PrideMonth is a reminder of the importance of allyship and inclusivity. For Trevor Hay, Legal Operations Coordinator, this month is a time to celebrate the LGBTQ+ community and the continued progress toward #equality. #Pride2024
-